Its oral drug o rforglipron , currently in phase 3 trials for obesity and T2D, is a daily oral GLP-1 that could appeal to patients that prefer not to inject themselves, as well as for patients that are located in geographies that lack the necessary cold chain infrastructure to adequately transport and store the injectables
Frequently Asked Questions Here are answers to common questions patients ask about semaglutide and eye health
Some pre-existing health conditions can mean you cant take GLP-1 medications, such as pancreatitis or certain thyroid cancers
Semaglutide mimics GLP-1, a hormone that naturally occurs in the body after eating
But so have the forces pushing patients toward compounding in the first place: brand drugs priced out of reach, limited insurance coverage, and middlemen who distort access
If any of your semaglutide pens or vials get exposed to extreme temperatures, and you need a refill, thats much easier to do when you have your prescription with you